Etelae-Karjalan hyvinvointialue
- Address
- lock Available on a paid plan
Neoplasms and Therapeutic Techniques and Equipment
At Etelae-Karjalan hyvinvointialue, clinical research in oncology focuses on metastatic or locally advanced inoperable colorectal cancer. The studies explore how this disease behaves in real-world care and aim to improve understanding of resectability, recovery after surgery, and overall treatment outcomes.
- Evaluating the clinical course of advanced colorectal cancer
- Assessing whether tumors can be surgically removed
- Studying postoperative morbidity and patient outcomes
This work supports better treatment planning and helps refine care for patients with complex colorectal cancer.
Therapeutics in Surgical Care
Another area of research at this hospital addresses venous thromboembolism in surgical patients. The trials are designed to test whether thromboprophylaxis can better balance the prevention of blood clots with the risk of bleeding during urologic, gynecologic, and general abdominal surgery.
- Comparing clot prevention strategies in surgery
- Studying safety and bleeding risk alongside benefit
- Supporting decisions in patients with uncertain VTE risk
The research aims to improve perioperative care by identifying when preventive treatment is most useful for patients at moderate risk of VTE.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1HUS-yhtymae2active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1HUS-yhtymae2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 107 other sites in Finland
Therapeutic Area Benchmark — Finland
Select a therapeutic area to compare against other sites in Finland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Finland
Market Share
Country: Finland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Etelae-Karjalan hyvinvointialue
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A phase 2b, multinational, randomized, double-blind study to investigate the efficacy and safety of redasemtide (S-005151) compared with placebo in adult participants with acute ischemic stroke | Shionogi B.V. | Phase II | Not Yet Recruiting | Feb 2024 | Jun 2026 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Apixaban | 1 | Unknown | 2024-05-31 | 2024-05-31 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.